Dronabinol and marijuana in HIV+ marijuana smokers: Acute effects on caloric intake and mood

Psychopharmacology

Volumn 181, Issue 1, 2005, Pages 170-178

  Haney, Margaret ^a   Rabkin, Judith ^a   Gunderson, Erik ^a   Foltin, Richard W ^a  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

AIDS; Appetite; Cannabinoids; THC

Indexed keywords

CANNABIS; DRONABINOL;

ADULT; APPETITE DISORDER; ARTICLE; BIOENERGY; CALORIC INTAKE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DIZZINESS; DRUG EFFECT; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HEADACHE; HUMAN; IMPEDANCE; INTOXICATION; MALE; MOOD; NAUSEA; PRIORITY JOURNAL; SMOKING; VOMITING;

ADULT; AFFECT; CAPSULES; DIARRHEA; DOSE-RESPONSE RELATIONSHIP, DRUG; EATING; ENERGY INTAKE; FEMALE; HEADACHE; HEART RATE; HIV SEROPOSITIVITY; HUMANS; HUNGER; MALE; MARIJUANA SMOKING; MENTAL RECALL; NAUSEA; PSYCHOTROPIC DRUGS; QUESTIONNAIRES; SATIETY RESPONSE; TASK PERFORMANCE AND ANALYSIS; TETRAHYDROCANNABINOL;

EID: 26644474134     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-005-2242-2     Document Type: Article

References (45)

1. Abrams DI (2000) Potential interventions for HIV/AIDS wasting: an overview. J Acquir Immune Defic Syndr 25:S74-S80
2. Abrams DI, Hilton JF, Leiser RJ, Shade SB, Elbeik TA, Aweeka FT, Benowitz NL, Bredt BM, Kosel B, Aberg JA, Deeks SG, Mitchell TF, Mulligan K, Bacchetti P, McCune JM, Schambelan M (2003) Short-term effects of cannabinoids in patients with HIV-1 infection. Ann Intern Med 139:258-266
3. 1 tetrahydrocannabinol and other cannabinoids with emphasis on man. Pharmacol Rev 38:21-43
4. Beal JE, Olson R, Laubenstein L, Morales JO, Bellman P, Yangco B, Lefkowitz L, Plasse TF, Shepard KV (1995) Dronabinol as a treatment for anorexia associated with weight loss in patients with AIDS. J Pain Symptom Manage 10:89-97
5. Beal JE, Olson R, Lefkowitz L, Laubenstein L, Bellman P, Yangco B, Morales JO, Murphy R, Powderly W, Plasse TF, Mosdell KW, Shepard KV (1997) Long-term efficacy and safety of dronabinol for acquired immunodeficiency syndrome-associated anorexia. J Pain Symptom Manage 14:7-14
6. Calhoun SR, Galloway GP, Smith DE (1998) Abuse potential of dronabinal (Marinol). J Psychoactive Drugs 30:187-196
7. Chait LD, Pierri J (1989) Some physical characteristics of NIDA marijuana cigarettes. Addict Behav 14:61-67
8. Cocchetto DM, Owens SM, Perez-Reyes M, DiGuiseppi S, Miller LL (1981) Relationship between plasma delta-9-tetrahydrocannabinol concentration and pharmacologic effects in man. Psychopharmacology 75:158-164
9. Compton WM, Grant BF, Colliver JD, Glantz MD, Stinson FS (2004) Prevalence of marijuana use disorders in the United States: 1991-1992 and 2001-2002. JAMA 291:2114-2121
10. Dworkin MS, Williamson JM (2003) AIDS wasting syndrome: trends, influence on opportunistic infections, and survival. J Acquir Immune Defic Syndr 33:267-273
11. ElSohly MA, Feng S, Murphy TP, Ross SA, Nimrod A, Mehmedic Z, Fortner N (1999) Delta 9-tetrahydrocannabivarin (delta 9-THCV) as a marker for the ingestion of cannabis versus Marinol. J Anal Toxicol 23:222-224
12. Evans SM, Troisi JR II, Griffiths RR (1994) Tandospirone and alprazolam: comparison of behavioral effects and abuse liability in humans. J Pharmacol Exp Ther 271:683-694
13. Evans SM, Haney M, Levin FR, Foltin RW, Fischman MW (1998) Mood and performance changes in women with premenstrual dysphoric disorder: acute effects of alprazolam. Neuropsychopharmacology 19:499-516
14. Foltin RW, Brady JV, Fischman MW (1986) Behavioral analysis of marijuana effects on food intake in humans. Pharmacol Biochem Behav 25:577-582
15. Foltin RW, Brady JV, Fischman MW, Emurian CS, Dominitz J (1987) Effects of smoked marijuana on social interaction in small groups. Drug Alcohol Depend 20:87-93
16. Foltin RW, Fischman MW, Byrne MF (1988) Effects of smoked marijuana on food intake and body weight of humans living in a residential laboratory. Appetite 11:1-14
17. Foltin RW, Haney M, Comer SD, Fischman MW (1996) Effect of fluoxetine on food intake of humans living in a residential laboratory. Appetite 27:165-181
18. Grinspoon L, Bakalar J (1993) Marihuana, the forbidden medicine. Yale University Press, New Haven
19. Hall W, Degenhardt L (2003) Medical marijuana initiatives: are they justified? How successful are they likely to be? CNS Drugs 17:689-697
20. Haney M, Ward AS, Comer SD, Foltin RW, Fischman MW (1999a) Abstinence symptoms following oral THC administration to humans. Psychopharmacology 141:385-394
21. Haney M, Ward AS, Comer SD, Foltin RW, Fischman MW (1999b) Abstinence symptoms following smoked marijuana in humans. Psychopharmacology 141:395-404
22. Haney M, Bisaga A, Foltin RW (2003) Interaction between naltrexone and oral THC in heavy marijuana smokers. Psychopharmacology 166:77-85
23. Haney M, Hart CL, Vosburg SK, Nasser J, Bennett A, Zubaran C, Foltin RW (2004) Marijuana withdrawal in humans: effects of oral THC or divalproex. Neuropsychopharmacology 29:158-170
24. Hart CL, van Gorp W, Haney M, Foltin RW, Fischman MW (2001) Effects of acute smoked marijuana on complex cognitive performance. Neuropsychopharmacology 25:757-765
25. Hart CL, Haney M, Ward AS, Fischman MW, Foltin RW (2002a) Effects of oral THC maintenance on smoked marijuana self-administration. Drug Alcohol Depend 67:301-309
26. 9-THC in humans. Psychopharmacology 164:407-415
27. Heatherington M, Rolls BJ (1987) Methods of investigating human eating behavior. In: Toates F, Rowland N (eds) Feeding and drinking. Elsevier, Amsterdam, pp 77-109
28. Institute of Medicine (1999) Marijuana and medicine: assessing the science base. National Academy Press, Washington, DC
29. 9- tetrahydrocannabinol in frequent and infrequent marijuana users. Pharmacol Biochem Behav 63:137-142
30. Kosel BW, Aweeka FT, Benowitz NL, Shade SB, Hilton JF, Lizak PS, Abrams DI (2002) The effects of cannabinoids on the pharmacokinetics of indinavir and nelfinavir. AIDS 16:543-550
31. Kotler DP, Burastero S, Wang J, Pierson RN (1996) Prediction of body cell mass, fat-free mass, and total body water with bioelectrical impedance analysis: effects of race, sex, and disease. Am J Clin Nutr 64:489S-497S
32. Martin BR (2002) Medical marijuana - moving beyond the smoke. Lancet 360:4-5
33. Mason AP, McBay AJ (1985) Cannabis: pharmacology and interpretation of effects. J Forensic Sci 30:615-631
34. Mattes RD, Engelman K, Shaw LM, Elsohly MA (1994) Cannabinoids and appetite stimulation. Pharmacol Biochem Behav 49:187-195
35. Palella FJ, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, Aschman DJ, Holmberg SD (1998) Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. New Engl J Med 338:853-860
36. Palenicek JP, Graham NMH, He YD, Hoover DA, Oishi JS, Kingsley L, Saah AJ (1995) Weight loss prior to clinical AIDS as a predictor of survival. Multicenter AIDS Cohort Study Investigators. J Acquir Immune Defic Syndr 10:366-373
37. Plasse TF, Gorter RW, Krasnow SH, Lane M, Shepard KV, Wadleigh RG (1991) Recent clinical experience with dronabinol. Pharmacol Biochem Behav 40:695-700
38. Polen MR, Sidney S, Tekawa IS, Sadler M, Friedman GD (1993) Health care use by frequent marijuana smokers who do not smoke tobacco. Western J Med 158:596-601
39. Pope HG, Gruber AJ, Hudson JI, Huestis MA, Yurgelun-Todd D (2001) Neuropsychological performance in long-term cannabis users. Arch Gen Psychiatry 58:909-915
40. Prentiss D, Power R, Balmas G, Tzuang G, Israelski DM (2004) Patterns of marijuana use among patients with HIV/AIDS followed in a public health care setting. J Acquir Immune Defic Syndr 35:38-45
41. Robson P (2001) Therapeutic aspects of cannabis and cannabinoids. Br J Psychol 178:107-115
42. Struwe M, Kaempfer SH, Geiger CJ, Pavia AT, Plasse TF, Shepard KV, Ries K, Evans TG (1993) Effect of dronabinol on nutritional status in HIV infection. Ann Pharmacother 27:827-831
43. Tashkin DP (1999) Marihuana and the lung. In: Nahas GG, Pace N, Cancro R (eds) Marihuana and medicine. Humana Press, Totowa, NJ, pp 279-287
44. Timpone JG, Wright DJ, Li N, Egorin MJ, Enama ME, Mayers J, Galetto G (1997) The safety and pharmacokinetics of single-agent and combination therapy with megestrol acetate and dronobinol for the treatment of HIV wasting syndrome. The DATRI 004 Study Group. Division of AIDS Treatment Research Initiative. AIDS Res Hum Retro viruses 13:305-315
45. Wu T, Tashkin DP, Djahed B, Rose JE (1988) Pulmonary hazards of smoking marijuana as compared with tobacco. New Engl J Med 318:347-351